- Merck stages expanded access to monthly HIV PrEP pill ahead of approvalFollowing in the footsteps of Gilead, Merck has signed voluntary licensing agreements to enable access to its investigational HIV PrEP pill alimatravir ahead of any regulatory submissions.Fierce Biotech · 12h ago↗ source
- Opinion: I may be one of the last middle-class medical students who could afford to become a doctorA federal loan program made it possible for Gauri Gurumurthy to pursue medicine. Now that program is changing.STAT · 13h ago↗ source
- Opinion: The U.S. pharmaceutical supply chain problem is not about ChinaThe national security framing of the discussion around pharmaceutical supply chain vulnerabilities is a distraction, writes Pooja Yerramilli.